Perry B Shieh1. 1. Department of Neurology, University of California, Los Angeles, California, USA.
Abstract
PURPOSE OF REVIEW: This article reviewed the most recent clinical trials investigating potential treatments for Duchenne muscular dystrophy (DMD). In the development of these studies, investigators have encountered unexpected challenges that reveal limitations in our understanding of the clinical trial design for this disease. RECENT FINDINGS: Recent clinical trials for DMD have revealed limitations in our understanding of the natural history of this disease. As a result of these revelations, there has been a significant effort to document the natural history of Duchenne and develop valid outcome measure that could be used in clinical trials in different subsets of patients. SUMMARY: Treatment for DMD is a rapidly changing field. Some of the drugs that are currently under investigation will receive Food and Drug Administration approval in the near future. These would become part of clinical practice. This article summarizes the different therapeutic approaches under investigation and illustrates the importance of defining sound research methods that are specific to the disease and population under investigation.
PURPOSE OF REVIEW: This article reviewed the most recent clinical trials investigating potential treatments for Duchenne muscular dystrophy (DMD). In the development of these studies, investigators have encountered unexpected challenges that reveal limitations in our understanding of the clinical trial design for this disease. RECENT FINDINGS: Recent clinical trials for DMD have revealed limitations in our understanding of the natural history of this disease. As a result of these revelations, there has been a significant effort to document the natural history of Duchenne and develop valid outcome measure that could be used in clinical trials in different subsets of patients. SUMMARY: Treatment for DMD is a rapidly changing field. Some of the drugs that are currently under investigation will receive Food and Drug Administration approval in the near future. These would become part of clinical practice. This article summarizes the different therapeutic approaches under investigation and illustrates the importance of defining sound research methods that are specific to the disease and population under investigation.
Authors: Mary Killian; Maciej S Buchowski; Thomas Donnelly; W Bryan Burnette; Larry W Markham; James C Slaughter; Meng Xu; Kimberly Crum; Bruce M Damon; Jonathan H Soslow Journal: Neuromuscul Disord Date: 2020-02-20 Impact factor: 4.296
Authors: Harneet Arora; Rebecca J Willcocks; Donovan J Lott; Ann T Harrington; Claudia R Senesac; Kirsten L Zilke; Michael J Daniels; Dandan Xu; Gihan I Tennekoon; Erika L Finanger; Barry S Russman; Richard S Finkel; William T Triplett; Barry J Byrne; Glenn A Walter; H Lee Sweeney; Krista Vandenborne Journal: Muscle Nerve Date: 2018-07-24 Impact factor: 3.217
Authors: Marshall W Hogarth; Peter J Houweling; Kristen C Thomas; Heather Gordish-Dressman; Luca Bello; Elena Pegoraro; Eric P Hoffman; Stewart I Head; Kathryn N North Journal: Nat Commun Date: 2017-01-31 Impact factor: 14.919
Authors: Ursula Moore; Marni Jacobs; Meredith K James; Anna G Mayhew; Roberto Fernandez-Torron; Jia Feng; Avital Cnaan; Michelle Eagle; Karen Bettinson; Laura E Rufibach; Robert Muni Lofra; Andrew M Blamire; Pierre G Carlier; Plavi Mittal; Linda Pax Lowes; Lindsay Alfano; Kristy Rose; Tina Duong; Katherine M Berry; Elena Montiel-Morillo; Irene Pedrosa-Hernández; Scott Holsten; Mohammed Sanjak; Ai Ashida; Chikako Sakamoto; Takayuki Tateishi; Hiroyuki Yajima; Aurélie Canal; Gwenn Ollivier; Valerie Decostre; Juan Bosco Mendez; Nieves Sánchez-Aguilera Praxedes; Simone Thiele; Catherine Siener; Jeanine Shierbecker; Julaine M Florence; Bruno Vandevelde; Brittney DeWolf; Meghan Hutchence; Richard Gee; Juliana Prügel; Elke Maron; Heather Hilsden; Hanns Lochmüller; Ulrike Grieben; Simone Spuler; Carolina Tesi Rocha; John W Day; Kristi J Jones; Diana X Bharucha-Goebel; Emmanuelle Salort-Campana; Matthew Harms; Alan Pestronk; Sabine Krause; Olivia Schreiber-Katz; Maggie C Walter; Carmen Paradas; Jean-Yves Hogrel; Tanya Stojkovic; Shin'ichi Takeda; Madoka Mori-Yoshimura; Elena Bravver; Susan Sparks; Jordi Díaz-Manera; Luca Bello; Claudio Semplicini; Elena Pegoraro; Jerry R Mendell; Kate Bushby; Volker Straub Journal: Neurology Date: 2019-01-09 Impact factor: 9.910